Lamivudine for the treatment of chronic hepatitis B
Verhelst, D.; Goffin, E.
New England Journal of Medicine 342(8): 592
2000
ISSN/ISBN: 0028-4793 PMID: 10691512 Document Number: 525185
Document emailed within 1 workday
Related Documents
Xu, J.-h.; Yu, Y.-y.; Si, C.-w.; Chen, X.-y.; Han, Z.-h.; Chen, Y.; Li, X.-y. 2009: A clinical study of viral dynamic change in patients with hepatitis B e antigen positive chronic hepatitis B by lamivudine treatment Zhonghua Yi Xue Za Zhi 89(41): 2902-2905Zoulim, F. 2000: Long-term treatment with lamivudine for chronic hepatitis B Gastroenterologie Clinique et Biologique 24(12): 1153-1154
Sarin, S.K.; Kumar, M.; Hissar, S.; Sharma, B.C. 2006: Combination of pegylated interferon and lamivudine for patients with chronic hepatitis B who have failed treatment Hepatobiliary and Pancreatic Diseases International: Hbpd Int 5(3): 374-380
Fung, J.; Lai, C.-L.; Yuen, J.C.-h.; Wong, D.K.-H.; Tanaka, Y.; Mizokami, M.; Yuen, M.-F. 2007: Adefovir dipivoxil monotherapy and combination therapy with lamivudine for the treatment of chronic hepatitis B in an Asian population Antiviral Therapy 12(1): 41-46
Chen, J.-L.; Wang, L.; Yan, J.; Zhang, L.; Yu, H.; Fan, X.-L. 2007: Predictive factors of hepatitis B virus DNA negative conversion among patients with chronic hepatitis B during lamivudine therapy Zhonghua Shi Yan he Lin Chuang Bing du Xue Za Zhi 21(3): 273-275
Akbar, H.O. 2002: Lamivudine in chronic hepatitis B virus Saudi Medical Journal 23(8): 929-933
Ozdemir, O.; Saylan, M.; Pakel, H.; Lescrauwaet, B. 2011: PIN8 a Decision Tree Model Comparing Clinical Outcomes of Treatment with Telbivudine with or without "Tenofovir Add-on as Needed" and Lamivudine with or without "Tenofovir Add-on as Needed" in the Treatment of Chronic Hepatitis B Infection in Turkey Value in Health 14(7): A266-A267
Ibragimova, M.M.; Abdurakhmanov, D.T.; Krel', P.E.; Lopatkina, T.N.; Ignatova, T.M.; Popova, I.V. 2003: Efficacy of lamivudine in HBeAg-negative chronic hepatitis B Klinicheskaia Meditsina 81(6): 49-52
Benhamou, Y. 2006: Treating chronic lamivudine-resistant hepatitis B in HIV co-infected patients Gastroenterologie Clinique et Biologique 30(10 Part 2): 3s22-3s25
Lewandowska, D.; Durlik, M.; Pazik, J.; Lewandowski, Z.; Lao, M.ła. 2003: The influence of lamivudine therapy on the course of chronic hepatitis B in renal allograft recipients Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 15(88): 367-370
Bai, H.-l.; Luo, H.-t.; Ye, Y.-n.; Long, H.; Zhong, R.-x. 2010: Observation on effect of peg interferon lphaa-2a treating lamivudine resistant chronic hepatitis B Zhonghua Shi Yan he Lin Chuang Bing du Xue Za Zhi 24(3): 230-231
Ozgenç, F.; Arikan, C.; Sertoz, R.Y.; Nart, D.; Aydogdu, S.; Yagci, R.V. 2004: Effect of long-term lamivudine in chronic hepatitis B virus-infected children Antiviral Therapy 9(5): 729-732
Sharma, Y.R.; Miah, A.R.; Saha, S.K.; Mohammed, S.; Rahman, M.; Roy, P.K.; Hasan, M. 2004: A study on efficacy of lamivudine therapy in decompensated cirrhosis of liver due to chronic hepatitis B virus infection Nepal Medical College Journal: Nmcj 6(2): 106-111
Kuloğlu, Z.; Kansu, A.; Erden, E.; Girgin, N. 2010: Efficacy of combined interferon alpha and long-term lamivudine therapy in children with chronic hepatitis B Turkish Journal of Pediatrics 52(5): 457-463
Manciuc, C.; Vâţă, A.; Dorobăţ, C.; Scurtu, R.; Petrovici, C.; Luca, V. 2004: Lamivudine and alpha-IFN treatment of a severe case of acute hepatitis B Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 108(1): 207-209
Van Thiel, D.H.; Friedlander, L.; Kania, R.J.; Molloy, P.J.; Hassanein, T.; Wahlstrom, E.; Faruki, H. 1997: Lamivudine treatment of advanced and decompensated liver disease due to hepatitis B Hepato-Gastroenterology 44(15): 808-812
Tseng, T-Chung.; Liu, C-Jen.; Wang, C-Chi.; Chen, P-Jer.; Lai, M-Yang.; Chen, D-Shinn.; Kao, J-Horng. 2009: Association of baseline viral factors with response to lamivudine therapy in chronic hepatitis B patients with high serum alanine aminotransferase levels Antiviral Therapy 14(2): 203-210
Tran, A.; Longo, F.; Saint-Paul, M.C.; Doglio, A.; Benzaken, S.; Rampal, P. 2000: Long-term lamivudine therapy for interferon-alpha- and/or adenine arabinoside monophosphate-resistant chronic hepatitis B infection. Results of a pilot study Gastroenterologie Clinique et Biologique 24(12): 1234-1235
Skiba, E.; Lebensztejn, D.M.; Werpachowska, I.; Kaczmarski, M. 2005: The evaluation of hyaluronic acid and laminin concentration in serum in children with chronic hepatitis B treated with lamivudine, unresponsive to previous interferon-alpha therapy Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 18(105): 268-270
Qian, F.; Qin, J.; Li Dongli; Wang Weihong; Dai, L. 2015: Variability of Reverse Transcriptase Gene and S Gene in Lamivudine-treated Chronic Hepatitis B Patients Bing du Xue Bao 31(4): 433-439